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Methods: Lupus nephritis is characterized by intrarenal infiltration and
activation of T-lymphocytes. The master transcription factors that control Th1-
and Th2-lymphocytes differentiation, T-bet and GATA-3, in the urinary sediment
of SLE patients were measured by the real-time quantitative polymerase chain
reaction and Western blotting. Urinary mRNA quantitation was performed on
100 SLE patients and 10 healthy subjects. Results: The urinary mRNA
expression of T-bet was significantly higher in SLE patients with active nephritis
than in those with inactive disease (p < 0.001). The T-bet mRNA expression
correlated with the disease activity in terms of the SLEDAI score (r = 0.55, p <
0.001), proteinuria (r = 0.51, p < 0.001), and the histologic activity index in
renal biopsy specimens (r = 0.48, p = 0.03). In contrast, the urinary GATA-3
mRNA expression was significantly suppressed in those with active nephritis
(p < 0.001), and inversely correlated with the SLEDAI score (r = 0.38, p <
0.001). Similarly, Western blot study on the urine of 42 SLE patients and 10
healthy subjects demonstrated that urinary T-bet level was significantly elevated
in patients with active nephritis (p = 0.006), while their GATA-3 level was
significantly suppressed (p = 0.008). The protein level of T-bet correlated with
the degree of kidney involvement in terms of renal score in SLEDAI (r = 0.40,
p = 0.016). Further, in SLE patients with inactive disease, a high urinary T-bet
to GATA-3 mRNA expression ratio was an independent predictor of future
disease flare (log-rank test, p = 0.021). Conclusions: Patients with SLE and
active nephritis have increased T-bet and suppressed GATA-3 expression in the
urinary sediment, indicating a predominant type-1 T-lymphocyte activation.
Measurement of gene expression in the urinary sediment may provide valuable
information for the assessment and monitoring of SLE patients.
Effect of instillation of peritoneal dialysate on pulmonary physiology in
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Methods: A cross-sectional, observational study was conducted to investigate
the effect of the presence of peritoneal dialysate on pulmonary physiology in
CAPD patients. Pulmonary function tests, including vital capacity (VC),
functional residual capacity (FRC) and total lung capacity (TLC) were recorded
before and after the instillation of 2 L 1.5% dextrose-based dialysate into the
peritoneal cavity. Changes in pulmonary physiological parameters were
correlated with patients’ height, body weight and intraperitoneal pressure (IPP).
Results: Fifty-four CAPD patients, receiving 6–8 L/day peritoneal dialysis for
at least 2 weeks, were recruited. Male-to-female ratio was 35:19, with a mean
age of 55.9 ( 12.5. Mean body height and weight were 160.8 ( 8.3 cm and
62.8 ( 10.6 kg respectively. IPP ranged from 15–30 cmH2O, with a mean of
20.2 ( 3.5 cmH2O. No difference in VC was observed before and after the
instillation of peritoneal dialysate (2.55 ( 0.62 L vs 2.56 ( 0.69 L respectively,
p = 0.792). TLC was reduced from 4.0 ( 1.03 L (empty abdomen) to 3.86 (
1.0 L (full abdomen) (p = 0.04). A reduction of FRC was also observed after
infusion of dialysate (2.0 ( 0.73 L vs 1.8 ( 0.73 L, p = 0.009). Patients’ IPP
levels did not correlate with the reductions of TLC and FRC (r = –0.13 and r =
–0.21 respectively, p > 0.05). There was also no correlation between change in
pulmonary function test parameters (TLC and FRC) and height or body weight.
Conclusions: The present study showed a significant reduction in TLC and
FRC after instillation of 2 L peritoneal dialysate that did not correlate with
patients’ body height, weight or IPP. These findings may be attributed to the
elevation of the diaphragm and increased diaphragmatic contractility secondary
to instillation of the peritoneal dialysate.
Prevalence of isolated microscopic hematuria and IgA nephropathy in
asymptomatic pregnant women
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Background: IgA nephropathy (IgAN) is the most common primary
glomerulonephritis worldwide. However, the actual prevalence of IgAN is
unknown. Most screening programs detect proteinuria, which is a late feature
of IgAN. Methods: We screened 7,828 consecutive pregnant women for
microscopic hematuria in the antenatal clinic of a tertiary referral center between
July 2000 and December 2001. Isolated microscopic hematuria was defined as
urine Hemostix (Bayer Diagnostics, HK) of 1+ for red cells in two clinic visits,
negative urine Albustix (Bayer Diagnostics) and bacterial culture, normal blood
pressure and serum creatinine, and no history of kidney disease. They were
referred to renal clinic for specialist evaluation. Results: There were 207 women
(2.64%) with microscopic hematuria. Mean age was 31.8 ( 5.0 years. In 101
patients (48.8%), there was proteinuria > 0.1 g/day by quantitative assay.
Hematuria was found to resolve before or shortly after delivery in 126 (60.9%)
and 66 women (31.9%) respectively. Five patients (2.4%) had urinary tract
infection proved by repeated urine culture, one had papillary necrosis, and one
had duplex collecting system. There were eight women (3.9%) with dysmorphic
red cell by urine microscopy, two of them were confirmed to have IgAN by
renal biopsy. Six women were lost to follow-up, including two in whom renal
biopsy was advised. The overall prevalence of IgAN in the population was
0.026% (95% CI, 0–0.061%). Conclusions: Microscopic hematuria is not
uncommon in pregnant women, and IgAN is present in a small but definite
proportion of these patients. Further study is needed to determine whether
screening for microscopic hematuria would allow early diagnosis and improve
the prognosis of these patients.
A prospective randomized study to evaluate erythropoietin treatment as a
novel strategy for improving vascular dysfunction and atherosclerosis
prevention in chronic renal failure
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Background: Anemia is highly prevalent in chronic renal failure (CRF) patient
and is predictive of cardiovascular outcomes. Objective: This prospective
randomized study over 48 weeks aimed to evaluate the effect of normalizing
hemoglobin (Hb) using erythropoietin (EPO) on atherogenesis in CRF subjects.
Methods: Sixty-six CRF subjects (serum creatinine, 150–700 +mol/L), with
no known cardiovascular disease and Hb < 11 g/dL, were randomized to receive
either weekly subcutaneous EPO 4,000 U (n = 32), dose up-titrating to achieve
and maintain Hb of 12–14 g/dL, or to the control group (n = 34). Flow-mediated
dilation (endothelium-dependent, FMD) of the brachial artery and carotid
intima-media thickness (IMT), both surrogate vascular markers, were measured
at baseline, week 24 and week 48 by a blinded investigator. Results: Baseline
characteristics were comparable for EPO and control groups. On multivariate
analysis, an increase in Hb was independently associated with an improvement
in FMD (` = 0.371, p = 0.005) while smoking, diabetes, in LDL-cholesterol
(LDL-C), systolic blood pressure and glomerular filtration rate (GFR) showed
no significant relationships with FMD.
Control group EPO group  p
(between-group
Baseline 48 wk Baseline 48 wk comparisons)
Hb (g/dL) 10.0 ( 1.01 9.2 ( 1.5*1 10.1 ( 0.71 13.4 ( 0.9* < 0.001
GFR (mL/min/1.73 m2) 14.5 ( 0.91 11.9 ( 1.0*11 14.3 ( 0.91 11.1 ( 1.0* 0.421
LDL-C (mmol/L) 2.98 ( 0.19 2.46 ( 0.17** 2.87 ( 0.17 2.52 ( 0.21 0.612
FMD (%) 5.55 ( 0.28 5.80 ( 0.3011 5.22 ( 0.341116.37 ( 0.28*** 0.009
IMT (mm) 0.70 ( 0.03 0.69 ( 0.0311 0.74 ( 0.03 0.72 ( 0.03 0.658
p = NS unless specified otherwise, *p < 0.001, **p < 0.005, ***p = 0.001, vs baseline.
Conclusions: Correction of anemia with EPO in CRF patients is associated
with significant improvement in vascular dysfunction, indicating a potential
novel strategy for atherosclerosis prevention in CRF.
